Annexin V detection of lipopolysaccharide-induced cardiac apoptosis

Shock

Volumn 27, Issue 1, 2007, Pages 69-74

  Pétillot, Patrice ^a,c,f   Lahorte, Christophe ^b   Bonanno, Elena ^d   Signore, Alberto ^e   Lancel, Steve ^a,f   Marchetti, Philippe ^a   Vallet, Benoit ^c   Slegers, Guido ^b   Neviere, Rémi ^f,g  

^a INSERM   (France)

^b Faculty of Pharmaceutical Sciences   (Belgium)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Faculty of Medicine   (France)

^g UNIV LILLE   (France)

Author keywords

Annexin V; Caspase inhibitors; Lipopolysaccharide; Myocardial apoptosis

Indexed keywords

BIOTIN; CASPASE 3; CASPASE INHIBITOR; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA NUCLEOTIDYLEXOTRANSFERASE; ENDOTOXIN; IODINE 123; IODINE 125; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; PHOSPHATIDYLSERINE; SERUM ALBUMIN I 125;

ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG UPTAKE; HEART; HEART MUSCLE CELL; MEDIASTINUM; NICK END LABELING; NONHUMAN; RAT; SIGNAL TRANSDUCTION; STAINING;

EID: 33845700606     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000235085.56100.38     Document Type: Article

References (25)

1. McDonald TE, Grinman MN, Carthy CM, Walley KR: Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am J Physiol 279:H2053-H2061, 2000.
2. Joshi VD, Kalvakolanu DV, Cross AS: Simultaneous activation of inflammation and apoptosis in pathogenesis of septic shock: a hypothesis. FEBS Lett 555:180-184, 2003.
3. Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P: Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Resp Crit Care Med 163:218-225, 2001.
4. Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW, Armstrong RC, Kitsis RN: Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gαq transgenic mice. Circulation 108:3036-3041, 2003.
5. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, Shirani J, Armstrong RC, Kitsis RN: A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497-1504, 2003.
6. Fauvel H, Marchetti P, Obert G, Joulin O, Chopin C, Formstecher P, Neviere R: Protective effect of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats. Am J Respir Crit Care Med 165:449-455, 2002.
7. Power C, Fanning N, Redmond HP: Cellular apoptosis and organ injury in sepsis: a review. Shock 18:197-211, 2002.
8. Gerke V, Moss SE: Annexins: from structure to function. Physiol Rev 82:331-371, 2002.
9. Van den Eijnde SM, Boshart L, Reutelingsperger CPM, De Zeeuw CI, Vermeij-Keers C: Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Differ 4:311-316, 1997.
10. Rücker-Martin C, Hénaff M, Hatem SN, Delpy E, Mercadier J-J: Early redistribution of plasma membrane phosphatidylserine during apoptosis of adult rat ventricular myocytes in vitro. Basic Res Cardiol 94:171-179, 1999.
11. van Heerde WL, Robert-Offerman S, Dumont E, Hofstra L, Reutelinsperger CPM: Markers of apoptosis in cardiovascular tissue: focus on annexin V. Cardiovasc Res 45:549-559, 2000.
12. Narayan P, Mentzer Jr RM, Lasley RD: Annexin V staining during reperfusion detects cardiomyocytes with unique properties. Am J Physiol 281:H1931-H1937, 2001.
13. Dumont EA, Hofstra L, Van Heerde WL, Reutelingsperger CPM: Cardiomyocyte death induced by myocardial ischemia and reperfusion. Circulation 102:1564-1568, 2000.
14. Fadok VA: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216, 1992.
15. Fadok VA: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85-90, 2000.
16. Savill J, Fadok V: Corpses clearances defines the meaning of cell death. Nature 407:784-788, 2000.
17. Courtney Frasch S, Henson PM, Kailey JM, Fadok VA, Bratton DL: Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cdelta. J Biol Chem 275:23065-23073, 2000.
18. Benevolensky D, Belikova Y, Mohammadzadeh R, Trouve P, Marotte F, Russo-MarieSamuel F, Samuel JL, Charlemagne D: Expression and localization of the annexins II, V, and VI in myocardium from patients with endstage heart failure. Lab Invest 80:123-133, 2000.
19. Reutelingsperger CPM, van Heerde WL: Annexin V, the regulator of phosphatidylserine-catalysed inflammation and coagulation. Cell Mol Life Sci 53:527-532, 1997.
20. Lahorte C, Slegers G, Philippe J, Van de Wiele C, Dierckx RA: Synthesis and in vitro evaluation of 123I-labelled human recombinant annexin V. Biomol Eng 2:51-53, 2001.
21. Lahorte C, van de Wiele C, Bacher K, van den Bossche B, Thierens H, van Belle S, Slegers G, Dierckx RA: Biodistribution and dosimetry study of 123Irh-annexin V in mice and humans. Nucl Med Commun 24:871-880, 2003.
22. Turnbull IR, Buchman TG, Javadi P, Woolsey CA, Hotchkiss RS, Karl IE, Coopersmith CM: Age disproportionately increases sepsis-induced apoptosis in the spleen and gut epithelium. Shock 22:364-368, 2004.
23. Efron PA, Tinsley K, Minnich DJ, Monterroso V, Wagner J, Lainee P, Lorre K, Swanson PE, Hotchkiss R, Moldawer LL: Increased lymphoid tissue apoptosis in baboons with bacteremic shock. Shock 21:566-571, 2004.
24. Levy RJ, Deutschman CS: Evaluating myocardial depression in sepsis. Shock 22:1-10, 2004.
25. Lancel S, Petillot P, Favory R, Stebach N, Lahorte C, Danze PM, Vallet B, Marchetti P, Neviere R: Expression of apoptosis regulatory factors during myocardial dysfunction in endotoxemic rats. Crit Care Med 33:492-496, 2005.